Hypera SA (1HYPE3)

Currency in BRL
26.26
-0.22(-0.83%)
Closed·
1HYPE3 Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 11 days
Fair Value
Day's Range
26.1126.26
52 wk Range
16.6232.39
Key Statistics
Bid/Ask
19.29 / 19.40
Prev. Close
26.16
Open
26.11
Day's Range
26.11-26.26
52 wk Range
16.62-32.39
Volume
1.72M
Average Volume (3m)
3.09M
1-Year Change
-5.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1HYPE3 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
28.84
Upside
+9.84%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Hypera SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Hypera SA Company Profile

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.

Employees
10481
Market
Brazil

Compare 1HYPE3 to Peers and Sector

Metrics to compare
1HYPE3
Peers
Sector
Relationship
P/E Ratio
20.4x12.1x−0.5x
PEG Ratio
−0.390.020.00
Price/Book
1.4x1.4x2.6x
Price / LTM Sales
2.5x1.6x3.2x
Upside (Analyst Target)
6.8%8.8%41.7%
Fair Value Upside
Unlock20.6%6.1%Unlock

Analyst Ratings

6 Buy
8 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 28.84
(+9.84% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.28%
Dividend Yield
4.45%
Industry Median 2.71%
Annualised payout
1.17
Paid unevenly
5-Years Growth
-0.67%
Growth Streak

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
-0.22 / 0.0055
Revenue / Forecast
1.08B / 1.46B
EPS Revisions
Last 90 days

1HYPE3 Income Statement

People Also Watch

19.99
TIMS3
+0.25%
15.56
BBDC4
-0.77%
13.38
BBDC3
-0.82%
5.12
JHSF3
+0.79%
11.79
SRNA3
0.00%

FAQ

What Stock Exchange Does Hypera SA ON Trade On?

Hypera SA ON is listed and trades on the B3 Stock Exchange stock exchange.

What Is the Stock Symbol for Hypera SA ON?

The stock symbol for Hypera SA ON is "1HYPE3."

What Is the Hypera SA ON Market Cap?

As of today, Hypera SA ON market cap is 16.59B.

What Is Hypera SA ON's Earnings Per Share (TTM)?

The Hypera SA ON EPS (TTM) is 1.28.

When Is the Next Hypera SA ON Earnings Date?

Hypera SA ON will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is 1HYPE3 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Hypera SA ON Stock Split?

Hypera SA ON has split 1 times.

How Many Employees Does Hypera SA ON Have?

Hypera SA ON has 10481 employees.

What is the current trading status of Hypera SA ON (1HYPE3)?

As of 26 Jul 2025, Hypera SA ON (1HYPE3) is trading at a price of 26.26, with a previous close of 26.16. The stock has fluctuated within a day range of 26.11 to 26.26, while its 52-week range spans from 16.62 to 32.39.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.